Showing results (41-50 of 149) with videos related to

Sort By:
Pageof 15
Blood|August 20, 2009
Plasmacytoid dendritic cells express TRAIL and induce CD4+ T-cell apoptosis in HIV-1 viremic patientsGeorg Stary, Irene Klein, Sabine Kohlhofer, et al.
Wiener Klinische Wochenschrift|October 16, 2016
Evaluation of efficacy of alemtuzumab in 5 patients with aplastic anemia and/or myelodysplastic neoplasmWolfgang Füreder, Sabine Cerny-Reiterer, Wolfgang R Sperr, et al.
International Journal of Molecular Sciences|September 27, 2025
Therapeutic Effects of Lurbinectedin in PARP Inhibitor-Resistant High-Grade Serous Ovarian Cancer Using Patient-Derived Cell Lines and Organoid ModelsAkshi Srivastava, Christine Unterweger, Sarah Guttmann, et al.
Leukemia Research|January 13, 2006
Systemic mastocytosis (SM) associated with chronic eosinophilic leukemia (SM-CEL): detection of FIP1L1/PDGFRalpha, classification by WHO criteria, and response to therapy with imatinibStefan Florian, Harald Esterbauer, Thomas Binder, et al.
Leukemia Research|May 18, 2007
Idiopathic cytopenia of undetermined significance (ICUS) versus low risk MDS: the diagnostic interfaceFriedrich Wimazal, Christa Fonatsch, Renate Thalhammer, et al.
Biomolecules|November 27, 2021
Overweight as a Favorable Clinical Biomarker for Checkpoint Inhibitor Therapy Response in Recurrent Gynecologic Cancer PatientsThomas Bartl, Arina Onoprienko, Gerda Hofstetter, et al.
Haematologica|April 2, 2009
A phase II study of bortezomib in patients with MALT lymphomaMarlene Troch, Constanze Jonak, Leonhard Müllauer, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|May 23, 2018
Activity of Pembrolizumab in Recurrent Cervical Cancer: Case Series and Review of Published DataMarlene Kranawetter, Sebastian Röhrich, Leonhard Müllauer, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|December 28, 2010
Aberrant expression of CD30 in neoplastic mast cells in high-grade mastocytosisKarl Sotlar, Sabine Cerny-Reiterer, Karina Petat-Dutter, et al.
Journal of Personalized Medicine|September 23, 2022
Corrected Allele Frequency of BRCA1/2 Mutations Is an Independent Prognostic Factor for Treatment Response to PARP-Inhibitors in Ovarian Cancer PatientsChristina T Grech, Dietmar Pils, Stefanie Aust, et al.
Pageof 15